Gitlitz, Barbara J <br/><br/>
Sorafenib in platinum-treated patients with extensive stage small cell lung cancer: a Southwest Oncology Group (SWOG 0435) phase II trial.  [electronic resource] 

 -  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer  Nov 2010 
 - 1835-40 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1556-1380 
<br/><br/><label>Standard No.: </label>10.1097/JTO.0b013e3181f0bd78  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--therapeutic use<br/>Benzenesulfonates--therapeutic use<br/>Drug Resistance, Neoplasm--drug effects<br/>Female<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Neoplasm Recurrence, Local--diagnosis<br/>Neoplasm Staging<br/>Niacinamide--analogs & derivatives<br/>Organoplatinum Compounds--therapeutic use<br/>Phenylurea Compounds<br/>Pyridines--therapeutic use<br/>Remission Induction<br/>Salvage Therapy<br/>Small Cell Lung Carcinoma--drug therapy<br/>Sorafenib<br/>Survival Rate<br/>Treatment Outcome